Literature DB >> 9811354

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.

J Richter1, L Beffa, U Wagner, P Schraml, T C Gasser, H Moch, M J Mihatsch, G Sauter.   

Abstract

To identify genetic changes linked to bladder cancer progression we analyzed 90 invasive transitional cell carcinomas (37 pT1 and 53 pT2-4) by comparative genomic hybridization. The most frequent alterations included 1q+ (37%), 5p+ (24%), 6q- (19%), 8p-(29%), 8q+ (37%), 9p- (31%), 9q- (23%), 11p-(24%), 11q- (22%), 17q+ (29%), and 20q+ (28%). Interestingly, there were three groups of alterations that frequently occurred together (9p- and 11q13+/ 20q+ and 11q13+ or 17q+/1q+ and 3p+ or 11q-). These loci might carry genes that interact with each other in specific molecular pathways. There were remarkable genetic similarities between minimally and deeply invasive tumors of different histological grades, including a similar number of aberrations per tumor and an equal frequency of most individual alterations. However, deletions of 5q, 6q, and 15q and gains of 5p, 7p, and Xq were significantly more frequent in pT2-4 than in pT1 carcinomas. These loci may harbor genes that are important for bladder cancer progression.

Entities:  

Mesh:

Year:  1998        PMID: 9811354      PMCID: PMC1853402          DOI: 10.1016/S0002-9440(10)65750-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Apparent correlation of sex chromosome loss and disease course in urothelial cancer.

Authors:  I Powell; M Tyrkus; E Kleer
Journal:  Cancer Genet Cytogenet       Date:  1990-11-01

2.  Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.

Authors:  U Wagner; K Süess; T Luginbühl; U Schmid; D Ackermann; T Zellweger; R Maurer; G Alund; H Knönagel; M Rist; P Jordan; H Moch; M J Mihatsch; T C Gasser; G Sauter
Journal:  J Pathol       Date:  1999-05       Impact factor: 7.996

3.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder.

Authors:  A J Proctor; L M Coombs; J P Cairns; M A Knowles
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

4.  Molecular genetic alterations in superficial and locally advanced human bladder cancer.

Authors:  J C Presti; V E Reuter; T Galan; W R Fair; C Cordon-Cardo
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

5.  Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

Authors:  J Richter; F Jiang; J P Görög; G Sartorius; C Egenter; T C Gasser; H Moch; M J Mihatsch; G Sauter
Journal:  Cancer Res       Date:  1997-07-15       Impact factor: 12.701

6.  Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.

Authors:  R Shipman; P Schraml; M Colombi; G Raefle; C U Ludwig
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

7.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Authors:  A Kallioniemi; O P Kallioniemi; D Sudar; D Rutovitz; J W Gray; F Waldman; D Pinkel
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

8.  Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

Authors:  P Cairns; M E Shaw; M A Knowles
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

9.  Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.

Authors:  M A Knowles; M E Shaw; A J Proctor
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.

Authors:  L M Coombs; D A Pigott; E Sweeney; A J Proctor; M E Eydmann; C Parkinson; M A Knowles
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  29 in total

Review 1.  Molecular biology of bladder cancer.

Authors:  William Martin-Doyle; David J Kwiatkowski
Journal:  Hematol Oncol Clin North Am       Date:  2015-01-31       Impact factor: 3.722

Review 2.  [Noninvasive and invasive bladder cancer: diagnostics and treatment].

Authors:  P J Goebell; F Vom Dorp; C Rödel; D Frohneberg; J W Thüroff; D Jocham; C Stief; S Roth; R Knüchel; K W Schmidt; I Kausch; D Zaak; C Wiesner; K Miller; R Sauer; H Rübben
Journal:  Urologe A       Date:  2006-07       Impact factor: 0.639

Review 3.  Chromosome 6p amplification and cancer progression.

Authors:  Gda C Santos; M Zielenska; M Prasad; J A Squire
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

4.  Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.

Authors:  Rosário Pinto-Leite; Isabel Carreira; Joana Melo; Susana Isabel Ferreira; Ilda Ribeiro; Jaqueline Ferreira; Marco Filipe; Carina Bernardo; Regina Arantes-Rodrigues; Paula Oliveira; Lúcio Santos
Journal:  Tumour Biol       Date:  2014-01-24

5.  Canine urothelial carcinoma: genomically aberrant and comparatively relevant.

Authors:  S G Shapiro; S Raghunath; C Williams; A A Motsinger-Reif; J M Cullen; T Liu; D Albertson; M Ruvolo; A Bergstrom Lucas; J Jin; D W Knapp; J D Schiffman; M Breen
Journal:  Chromosome Res       Date:  2015-03-18       Impact factor: 5.239

Review 6.  What we could do now: molecular pathology of bladder cancer.

Authors:  M A Knowles
Journal:  Mol Pathol       Date:  2001-08

7.  Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

Authors:  Keita Uchino; Fumitaka Takeshita; Ryou-U Takahashi; Nobuyoshi Kosaka; Kae Fujiwara; Haruna Naruoka; Satoru Sonoke; Junichi Yano; Hideo Sasaki; Shiari Nozawa; Miki Yoshiike; Kazuki Kitajima; Tatsuya Chikaraishi; Takahiro Ochiya
Journal:  Mol Ther       Date:  2013-01-08       Impact factor: 11.454

Review 8.  Molecular pathogenesis of bladder cancer.

Authors:  Margaret A Knowles
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

Review 9.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

10.  Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.

Authors:  Kerstin Junker; Johanna M M van Oers; Ellen C Zwarthoff; Ines Kania; Joerg Schubert; Arndt Hartmann
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.